4. MATERIEL SOLUTION ANALYSIS
Purpose. The purpose of this phase is to assess potential
materiel solutions and to satisfy the phase-specific entrance criteria for the
next program milestone designated by the MDA.
Entrance Criteria. Entrance into this phase depends upon an
approved ICD resulting from the analysis of current mission performance and an
analysis of potential concepts across the DoD Components, international
systems from allies, and cooperative opportunities.
The Materiel Solution Analysis Phase begins with the Materiel Development
Decision review. The Materiel Development Decision review is the formal entry
point into the acquisition process and shall be mandatory for all programs. Table
3 in Enclosure 4 identifies all
regulatory requirements for the Materiel Development Decision review.
Funding for this phase shall normally be limited to satisfaction of the
Materiel Solution Analysis Phase objectives.
At the Materiel Development Decision review, the Joint Staff shall present the
JROC recommendations and the DoD Component shall present the ICD including:
the preliminary concept of operations, a description of the needed capability,
the operational risk, and the basis for determining that non-materiel
approaches will not sufficiently mitigate the capability gap. The Director,
Program Analysis & Evaluation (DPA&E), (or DoD Component equivalent)
shall propose study guidance for the Analysis of Alternatives (AoA).
The MDA shall approve the AoA study guidance; determine the acquisition phase
of entry; identify the initial review milestone; and designate the lead DoD
Component(s). MDA decisions shall be documented in an Acquisition Decision
Memorandum (ADM). The MDA’s decision to begin Materiel Solution Analysis DOES
NOT mean that a new acquisition program has been initiated.
Following approval of the study guidance, the lead DoD Component(s) shall
prepare an AoA study plan to assess preliminary materiel solutions, identify
key technologies, and estimate life-cycle costs. The purpose of the AoA is to
assess the potential materiel solutions to satisfy the capability need
documented in the approved ICD.
The ICD and the AoA study guidance shall guide the AoA and Materiel Solution
Analysis Phase activity. The AoA shall focus on identification and analysis of
alternatives, measures of effectiveness, cost, schedule, concepts of
operations, and overall risk. The AoA shall assess the critical technology
elements (CTEs) associated with each proposed materiel solution, including
technology maturity, integration risk, manufacturing feasibility, and, where
necessary, technology maturation and demonstration needs. To achieve the best
possible system solution, emphasis shall be placed on innovation and
competition. Existing commercial-off-the-shelf (COTS) functionality and
solutions drawn from a diversified range of large and small businesses shall
If the MDA determines that the initial review milestone specified at the
Materiel Development Decision is inconsistent with the maturity of the
preferred materiel solution, an alternative review milestone shall be
The Materiel Solution Analysis Phase ends when the AoA has been completed,
materiel solution options for the capability need identified in the approved
ICD have been recommended by the lead DoD Component conducting the AoA, and
the phase-specific entrance criteria for the initial review milestone have